India’s New Draft Bill Will Treat Crypto As A Commodity: Report
A new draft bill from the government of India will treat cryptocurrencies as commodities, according to a report from The Economic Times.
‘DOJ preps to sue over Google’s ad tech, even without its antitrust chief’ -POLITICO
https://www.politico.com/newsletters/morning-tech/2021/09/07/doj-preps-to-sue-over-googles-ad-tech-even-without-its-antitrust-chief-797440
CorMedix Says Was Informed By Contract Manufacturer That There Are Issues Unrelated To DefenCath Manufacturing Activities; Timeline For Co. and CMO To Address Deficiencies That Are Required For Resubmission Of DefenCath NDA Is Uncertain
CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today provided an update
ANALYSIS: Is Federal Regulation Of Cryptocurrency Coming Anytime Soon, If At All?
When Congress reconvenes later this month, one of the items that it may consider is the regulation of cryptocurrency. Sen. Pat Toomey (R-PA), the ranking member of the Senate Banking Committee, has been particularly eager to have this issue addressed.
CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Receipt Of GMC Authorization Permitting Cosmetic Product Manufacturing
Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced that it has received Good Manufacturing Practices (“GMP”) certification from the Colombian
Why Are DiDi Shares Trading Higher Today?
Bloomberg reporter tweeted that the China government wants to take DiDi Global Inc (NYSE:DIDI) under state control. China’s Uber Technologies (NYSE:UBER) counterpart, which…
How ByteDance Emulated Alibaba To Tide Through China’s Fintech Crackdown?
TikTok parent ByteDance will shrink its financial services unit and planned to sell its stockbroking operations in response…
Congress Asks For Approval Documents Of Biogen’s Alzheimer’s Drug: Report
Lawmakers have requested data and documents from the FDA related to the agency's controversial approval of Biogen Inc's (NASDAQ: BIIB) Alzheimer's drug Aduhelm.
Watching Brokerage Stocks, Traders Circulate Comments From SEC Chair Gensler ‘Brokerage apps & wealth management apps have helped broaden access to our capital markets for everyday investors. But how we can ensure investors are still protected…’
https://twitter.com/GaryGensler/status/1433510943292633088